Proteomics

Dataset Information

0

LC-MS/MS data for HCA mRNA antibodies


ABSTRACT: Fc N-glycosylation of IgGs is necessary for effector functions and is a crucial component of quality control. Fc N-glycan profiles of HCA produced by two platforms were determined using mass spectrometry which revealed major differences in site occupancy, glycan types, and glycoform distribution.

INSTRUMENT(S): Orbitrap Fusion Lumos

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Cell Culture

SUBMITTER: Chaoshuang Xia  

LAB HEAD: Catherine E. Costello

PROVIDER: PXD047910 | Pride | 2024-05-22

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
090921_HCA_N_IgG.raw Raw
090921_HCA_N_IgG.xlsx Xlsx
20220701_HCA_mRNA_VK2_IgG.raw Raw
20220701_HCA_mRNA_VK2_IgG.xlsx Xlsx
20230802_HCA_N_IgG_18O_Deglycosylated.raw Raw
Items per page:
1 - 5 of 9
altmetric image

Publications

Platform-Specific Fc <i>N</i>-Glycan Profiles of an Antisperm Antibody.

Nador Ellena E   Xia Chaoshuang C   Santangelo Philip J PJ   Whaley Kevin J KJ   Costello Catherine E CE   Anderson Deborah J DJ  

Antibodies (Basel, Switzerland) 20240306 1


IgG Fc <i>N</i>-glycosylation is necessary for effector functions and is an important component of quality control. The choice of antibody manufacturing platform has the potential to significantly influence the Fc glycans of an antibody and consequently alter their activity and clinical profile. The Human Contraception Antibody (HCA) is an IgG1 antisperm monoclonal antibody (mAb) currently in clinical development as a novel, non-hormonal contraceptive. Part of its development is selecting a suit  ...[more]

Similar Datasets

2020-06-29 | PXD016175 | Pride
2020-10-26 | PXD014710 | Pride
2022-08-12 | PXD027573 | Pride
2024-03-20 | GSE254483 | GEO
2024-03-21 | PXD046510 | Pride
2005-07-04 | E-MEXP-379 | biostudies-arrayexpress
2020-10-22 | PXD020329 | Pride
2016-06-08 | PXD004247 | Pride
2014-03-31 | E-GEOD-52031 | biostudies-arrayexpress
2017-12-06 | E-MTAB-5427 | biostudies-arrayexpress